Cresset Asset Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $389K | Sell |
33,574
-6,877
| -17% | -$79.6K | ﹤0.01% | 1179 |
|
|
2025
Q1 | $353K | Sell |
40,451
-1,168
| -3% | -$10.2K | ﹤0.01% | 1219 |
|
|
2024
Q4 | $598K | Sell |
41,619
-95,302
| -70% | -$1.37M | ﹤0.01% | 985 |
|
|
2024
Q3 | $3.09M | Buy |
136,921
+60,774
| +80% | +$1.37M | 0.01% | 597 |
|
|
2024
Q2 | $1.48M | Buy |
76,147
+17,543
| +30% | +$341K | 0.01% | 846 |
|
|
2024
Q1 | $2.2M | Sell |
58,604
-2,398
| -4% | -$90K | 0.01% | 590 |
|
|
2023
Q4 | $3.41M | Buy |
61,002
+10,125
| +20% | +$567K | 0.02% | 406 |
|
|
2023
Q3 | $2.1M | Sell |
50,877
-4,502
| -8% | -$186K | 0.01% | 512 |
|
|
2023
Q2 | $3.09M | Buy |
+55,379
| New | +$3.09M | ﹤0.01% | 402 |
|
|
2021
Q4 | – | Sell |
-4,058
| Closed | -$590K | – | 1298 |
|
|
2021
Q3 | $590K | Sell |
4,058
-657
| -14% | -$95.5K | 0.01% | 560 |
|
|
2021
Q2 | $924K | Sell |
4,715
-1,089
| -19% | -$213K | 0.01% | 381 |
|
|
2021
Q1 | $1.05M | Buy |
+5,804
| New | +$1.05M | 0.02% | 289 |
|